Deutsche Bank’s CORMEDIX INC WTS EXP 04/30/15 CRMD.WS Stock Holding History

Deutsche Bank’s Portfolio CRMD.WS Stock Details CRMD.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-29,608	Closed	-$2K	–	6442
2014 Q4	$2K	Hold	29,608	–	–	﹤0.01%	6051
2014 Q3	$10K	Hold	29,608	–	–	﹤0.01%	5398
2014 Q2	$14K	Buy	+29,608	New	+$12.3K	﹤0.01%	5430

Other funds holding CRMD.WS

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank's CRMD.WS Position: Q1 2015 in Review

Deutsche Bank sold out of CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) in Q1 2015, closing a stake of 29,608 shares — an estimated $2K sold.

Deutsche Bank first reported a position in CRMD.WS in Q2 2014 and held it in 3 quarters. The position peaked at $14K in Q2 2014. 4 funds tracked by Wall St. Rank hold CRMD.WS as of Q1 2015.

Deutsche Bank reported no remaining CORMEDIX INC WTS EXP 04/30/15 position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 29,608 CORMEDIX INC WTS EXP 04/30/15 shares in Q1 2015, an estimated $2K.
Deutsche Bank first reported a position in CORMEDIX INC WTS EXP 04/30/15 in Q2 2014 and held it in 3 quarters.
Deutsche Bank's CORMEDIX INC WTS EXP 04/30/15 position peaked at $14K in Q2 2014.
4 funds tracked by Wall St. Rank held CORMEDIX INC WTS EXP 04/30/15 as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.